Oblimersen sodium is a BCL-2 inhibitor targeting BCL-2 RNA. Oblimersen sodium specifically binds to the first six codons of the bcl-2 mRNA sequence, resulting in degradation of bcl-2 mRNA and induces apoptosis by down-regulating expression of Bcl-2. Oblimersen sodium can be used for cancer research[1][2][3].
Molecular Weight:
5684.61 (free acid)
Purity:
98.09
Formula:
C172H204N62Na17O91P17S17
Target:
Apoptosis,Bcl-2 Family
Application Notes:
MCE Product type: Oligonucleotides
* VAT and and shipping costs not included. Errors and price changes excepted